awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38817102-BD0B8263-D5E8-4257-A390-C731463D6A37
Q38817102-BD0B8263-D5E8-4257-A390-C731463D6A37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38817102-BD0B8263-D5E8-4257-A390-C731463D6A37
Targeting the ATR-CHK1 Axis in Cancer Therapy
P2860
Q38817102-BD0B8263-D5E8-4257-A390-C731463D6A37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38817102-BD0B8263-D5E8-4257-A390-C731463D6A37
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d24d54837c61ebc2de95e37f2421a0376f0f0120
P2860
Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.